首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Endovascular management of central thoracic veno-occlusive diseases in hemodialysis patients: a single institutional experience in 69 consecutive patients.
【24h】

Endovascular management of central thoracic veno-occlusive diseases in hemodialysis patients: a single institutional experience in 69 consecutive patients.

机译:血液透析患者中​​枢性胸腔静脉阻塞性疾病的血管内管理​​:连续69名患者的单一机构经验。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To assess the functional status and long-term outcomes of endovascular management for the treatment of central veno-occlusive disease in patients undergoing hemodialysis. MATERIALS AND METHODS: Retrospective chart evaluation of 600 patients with threatened upper extremity dialysis access showed central veno-occlusive disease in 69 patients (11%; 30 women and 39 men; mean age, 63.9 years; age range, 26-92 years). A total of 92 venous segments were involved with disease. Initial endovascular procedures consisted of transvenous angioplasty (n = 88) and stent placement (n = 6); there were 134 repeat interventions (14 stents). The mean follow-up was 14.5 months (range, 1-44 months). Angiographic data were reviewed prospectively by two independent observers for the extent of veno-occlusive disease. Technical failures were defined as residual stenosis of at least 30% or lesions that were unable to be dilated or crossed. Statistical analysis, including interobserver agreement and Kaplan-Meier analysis, was performed. RESULTS: Technical success rates for initial and follow-up interventional procedures were 90% (81 of 92 segments) and 96% (129 of 134 interventions), respectively. Two complications required treatment with interventional procedures. There was excellent interobserver agreement (kappa = 0.84; 95% confidence interval: 0.67, 0.93) for grading the degree of venous stenoses. Primary patency rates of hemodialysis access at 1, 6, and 12 months were 81%, 46%, and 22%, respectively, which significantly (P = .001) improved to assisted patency rates of 91%, 77%, and 63% at 1, 6, and 12 months, respectively. CONCLUSIONS: Endovascular management including a combination of angioplasty and selective stent placement can be effectively used to treat central veno-occlusive disease and preserve functional access in patients with threatened upper extremity dialysis access.
机译:目的:评估接受血液透析患者中​​枢性闭塞性疾病的血管内治疗的功能状态和长期结果。材料与方法:回顾性图表评估了600例有上肢透析威胁的患者,其中69例患有中央静脉阻塞性疾病(11%; 30名女性和39名男性;平均年龄63.9岁;年龄范围26-92岁)。共有92个静脉段与疾病有关。最初的血管内手术包括经静脉血管成形术(n = 88)和支架置入(n = 6);进行了134次重复干预(14个支架)。平均随访14.5个月(范围1-44个月)。两名独立的观察者对静脉造影闭塞性疾病的范围进行了前瞻性回顾。技术故障定义为残余狭窄至少30%或无法扩张或交叉的病变。进行了统计分析,包括观察者之间的一致性和Kaplan-Meier分析。结果:初始和后续干预程序的技术成功率分别为90%(92个环节中的81个)和96%(134个干预中的129个)。两种并发症需要介入治疗。观察者对静脉狭窄度的分级具有极好的观察者间一致性(kappa = 0.84; 95%置信区间:0.67、0.93)。在1、6和12个月时,血液透析通路的主要通畅率分别为81%,46%和22%,这显着(P = .001)提高到辅助通畅率分别为91%,77%和63%分别在1、6和12个月。结论:血管内处理包括血管成形术和选择性支架置入的结合可以有效地用于治疗中心静脉闭塞性疾病,并保留上肢透析通路受到威胁的患者的功能通路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号